CALL US AT 800-952-0521

Allergan to launch TV ad for Chronic Migraine

On June 24, 2013, a 60-second television advertisement will debut promoting BOTOX® (onabotulinumtoxinA) as a prophylactic treatment for adult patients living with Chronic Migraine (defined as experiencing 15 or more headache days per month, each lasting 4 hours a day or more).1

Important Limitations
Safety and effectiveness have not been established for the prophylaxis of episodic migraine (14 headache days or fewer per month) in 7 placebo-controlled studies.

We’d like to emphasize that BOTOX® and BOTOX® Cosmetic (onabotulinumtoxinA) are FDA approved for different uses, different injection sites, and different dosages. It is important to understand that BOTOX® for appropriate Chronic Migraine patients is for those patients who are diagnosed as having ≥ 15 headache days per month with headache lasting 4 hours a day or longer, and that only BOTOX® can be used and reimbursed by insurance providers for this indication.

Allergan looks forward to our continued support of your practice with BOTOX® Cosmetic and the entire Allergan Medical portfolio of products.

Lynn Salo
Vice President

Sales & Marketing—Facial Aesthetics

Click here for the announcement.

Gettrained

Blog Categories

Related Posts

Botulinum Toxin Options

By Sydney Gatta, RN We’ve all heard of Botox, right?! While Botox has been around for a very long time, it has become wildly more